<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160408027277N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-10-06</date_registration>
      <primary_sponsor>Arak University of Medical Sciences</primary_sponsor>
      <public_title>Laser therapy and Cryosurgery in the treatment of Gingival Physiologic Hyperpigmentation</public_title>
      <acronym></acronym>
      <scientific_title>A Comparison of 940 nm Diode Laser and Cryosurgery with Liquid  Nitrogen in the Treatment of Gingival Physiologic Hyperpigmentation using Split Mouth Technique</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2015-03-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>15</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/28866</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Maxillary gingiva of each patient was split into right and left halves (Split Mouth technique). One half was treated by 940 nm diode laser and the other half by cryosurgery. The divided areas were randomly allotted for depigmentation by coin toss, Blinding description: The study is designed double blinded so that the participants in the study (patients) are unaware of the type of intervention implemented on their gums and the experts reviewing the results of the two interventions are also unaware of the type of intervention done on the patients' gingival sites. In order to achieve the goals of blindness in this study, it needs to be explained that the expert doing the surgical procedure is different from the one evaluating the results of the two surgical procedures and the expert evaluator is completely unaware of the type of surgical method used in the surgical sites and is selected from outside of the surgical team.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Physiologic Gingival Hyperpigmentation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: 940 nm Diode Laser, EpicTM 10 diode type with wavelength of 940±10 nm, operating maximum power output of 10W, 0.01 ms to 20 s pulse duration, contact continuous mode, with 300 μm fiber tip diameter, spot size 30mm diameter (= 7.1 cm2 area) and manufactured by Biolase Company, USA. Firstly, gingiva received anesthesia with 2% lidocaine and the tip of laser was placed and moved on the entire pigmented area from the mucogingival line towards the free gingival margin, including the papillae until the pigmented area was de-epithelialized and a normal pink color of gingiva was apparent. The carbonized gingiva was wiped with a moist sterile gauze to ensure that no pigmented spots remained. Intervention 2: Intervention group 2: Cryotherapy with liquid Nitrogen, a 10-liter three-chambered tank of liquid nitrogen (-196°C), made in China, was used. Some liquid nitrogen was poured inside a plastic cup and the tip of a cotton swab was dipped in the liquid and placed inside a small finger-like plastic and then placed on the pigmented gingiva for 3 to 5 seconds. Sessions of cryosurgery was repeated until depigmentation was satisfactory.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is After the publication of this article in a journal if the privacy of patients is not invaded information will be given to the respected center.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Mohammad Keivan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Between Andisheh 5 and 6 Alleys, Ghadir Blvd., Nabaei town, Sardasht</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3848153793</zip>
        <telephone>+98 86 3272 4522</telephone>
        <email>keivan57@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mohammad Keivan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Between Andisheh 5 and 6 Alleys, Ghadir Boulevard, Nabaei town</address>
        <city>Arak</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3848159345</zip>
        <telephone>+98 86 3272 4522</telephone>
        <email>keivan57@gmail.com</email>
        <affiliation>Arak University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Physiologic Gingival Hyperpigmentaion</inclusion_criteria>
      <agemin>17 years</agemin>
      <agemax>35 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Amalgam tattoo
Oral melanotic macule
Malignant melanoma
Drug-induced melanosis
Smoker's melanosis
Melanosis associated with systemic and genetic diseases
Hemochromatosis
Graphite tattoo
Decorative tattoos
Pigmentation due to pharmaceutical and heavy metals
Pregnancy-related pigmentation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: 940 nm Diode Laser, EpicTM 10 diode type with wavelength of 940±10 nm, operating maximum power output of 10W, 0.01 ms to 20 s pulse duration, contact continuous mode, with 300 μm fiber tip diameter, spot size 30mm diameter (= 7.1 cm2 area) and manufactured by Biolase Company, USA. Firstly, gingiva received anesthesia with 2% lidocaine and the tip of laser was placed and moved on the entire pigmented area from the mucogingival line towards the free gingival margin, including the papillae until the pigmented area was de-epithelialized and a normal pink color of gingiva was apparent. The carbonized gingiva was wiped with a moist sterile gauze to ensure that no pigmented spots remained.</i_keyword>
      <i_keyword>Intervention group 2: Cryotherapy with liquid Nitrogen, a 10-liter three-chambered tank of liquid nitrogen (-196°C), made in China, was used. Some liquid nitrogen was poured inside a plastic cup and the tip of a cotton swab was dipped in the liquid and placed inside a small finger-like plastic and then placed on the pigmented gingiva for 3 to 5 seconds. Sessions of cryosurgery was repeated until depigmentation was satisfactory.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Physiologic Gingival Pigmentation Index. Timepoint: Before treatment, 3, 7, 10, 17, 21 days and 1, 3, 6, 12 months post-operatively. Method of measurement: Observation.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Post-operative pain. Timepoint: On the day of treatment. Method of measurement: Questionnaire.</sec_outcome>
      <sec_outcome>Duration of Gingival healing. Timepoint: Before treatment, 3, 7, 10,  14,17 and 21 days post-operatively. Method of measurement: Observation.</sec_outcome>
      <sec_outcome>Pigmentation recurrence. Timepoint: 1, 3, 6, 12 months after the treatment. Method of measurement: Observation.</sec_outcome>
      <sec_outcome>Patient satisfaction. Timepoint: one year after treatment. Method of measurement: questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Arak University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-02-20</approval_date>
        <contact_name>Ethics committee of Arak University of Medical Sciences</contact_name>
        <contact_address>Arak University of Medical Sciences, Basij Square, Sardasht, Khalij Fars Boulevard Arak Markazi Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
